| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | United States | 3 | |
| #3 | China | 2 | |
| #4 | New Zealand | 2 | |
| #5 | Canada | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Israel | 1 | |
| #8 | Norway | 1 | |
| #9 | Taiwan | 1 | |
| #10 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chang Kwen-Jen | 13 |
| #2 | Pendergast William | 8 |
| #3 | Ma Xin | 7 |
| #4 | Biciunas Kestutis P | 5 |
| #5 | Jan Shyi-Tai | 5 |
| #6 | Gengo Peter J | 4 |
| #7 | Xin Ma | 2 |
| #8 | Mcnutt Robert W Jr | 1 |
| #9 | William Pendergast | 1 |
| #10 | Holt Jonathon Daryll Schwarz | 1 |
| Publication | Filing date | Title |
|---|---|---|
| TW200803856A | Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity | |
| EP1874315A2 | Compositions of novel opioid compounds and method of use thereof | |
| US2006004016A1 | Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent | |
| US7314880B2 | Cardioprotective delta opioid receptor agonists and methods of using same |